A year ago, President Trump pledged to lower Medicaid drug prices. Has that happened?

Pfizer CEO Albert Bourla joined President Trump at the White House last year on Sept. 30 to announce a voluntary agrreement to reduce some prescription drug prices. One element aimed to lower prices in the taxpayer-funded Medicaid program, but the program is still being built, and details about which drugs will be discounted remain under wraps.

The Trump administration’s efforts to lower drug prices included promised changes to Medicaid. But it’s still unclear which drugs will be affected. And each state has to opt in.

(Image credit: Win McNamee)

Source Author
Author: Source Author

Source: NPR.

Written by

Sydney Lupkin

in

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

More posts